Hyd firm gets nod for Covid antidote VINCOV-19 trials

Immunologicals player VINS Bioproducts Ltd on Monday said it has received approval from the Drugs Controller General of India (DCGI) for conducting clinical trials of its Covid-19 antidote VINCOV-19.

from Hyderabad News: Latest Hyderabad News Headlines & Live News Updates from Hyderabad - Times of India https://ift.tt/32QoJh7